Effects of evolocumab (AMG 145) on vitamin e and serum adrenal and gonadal hormone levels; results from the 52-week, phase 3, double-blind, randomized, placebo-controlled descartes study. Issue 1 (July 2015)

Record Type:
Journal Article
Title:
Effects of evolocumab (AMG 145) on vitamin e and serum adrenal and gonadal hormone levels; results from the 52-week, phase 3, double-blind, randomized, placebo-controlled descartes study. Issue 1 (July 2015)
Main Title:
Effects of evolocumab (AMG 145) on vitamin e and serum adrenal and gonadal hormone levels; results from the 52-week, phase 3, double-blind, randomized, placebo-controlled descartes study
Authors:
Blom, D.
Djedjos, C.S.
Tsirtsonis, K.
Wasserman, S.M.
Scott, R.
Roth, E.
Abstract:
Is Part Of:
Atherosclerosis. Volume 241:Issue 1(2015)
Journal:
Atherosclerosis
Issue:
Volume 241:Issue 1(2015)
Issue Display:
Volume 241, Issue 1 (2015)
Year:
2015
Volume:
241
Issue:
1
Issue Sort Value:
2015-0241-0001-0000
Page Start:
e67
Page End:
Publication Date:
2015-07
Subjects:
Arteriosclerosis -- Periodicals
Electronic journals
616.136
Journal URLs:
http://www.sciencedirect.com/science/journal/00219150 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/00219150 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.atherosclerosis.2015.04.236 ↗
Languages:
English
ISSNs:
0021-9150
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 1765.874000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
3263.xml